| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2014) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC19 |
| UNII: | 4FR53SIF3A |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| CROSS-LINKING AGENT | B-lymphocyte antigen CD19 cross-linking agent | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054198 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 2 | D015456 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 2 | D015456 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Multiple Myeloma | 0 | D009101 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 853426-35-4 |
| ChEMBL | CHEMBL1742992 |
| FDA SRS | 4FR53SIF3A |
| Guide to Pharmacology | 7384 |
CONTENTS